Lee-Hwa Tai

Lee-Hwa Tai

Université de Sherbrooke

H-index: 23

North America-Canada

About Lee-Hwa Tai

Lee-Hwa Tai, With an exceptional h-index of 23 and a recent h-index of 17 (since 2020), a distinguished researcher at Université de Sherbrooke, specializes in the field of Cancer Immunology, Immunotherapy.

His recent articles reflect a diverse array of research interests and contributions to the field:

Fatty acid transport protein inhibition sensitizes breast and ovarian cancers to oncolytic virus therapy via lipid modulation of the tumor microenvironment

CAnAdIAn BlAdder CAnCer ForUm 2023

Perioperative oncolytic virotherapy to counteract surgery-induced immunosuppression and improve outcomes in pancreatic ductal adenocarcinoma

Heterologous prime-boost cellular vaccination induces potent antitumor immunity against triple negative breast cancer

Gemcitabine promotes autophagy and lysosomal function through ERK-and TFEB-dependent mechanisms

Remodeling the tumor immune microenvironment with oncolytic viruses expressing miRNAs

Born to kill: arming oncolytic virus VSV-TNFSF14/light to treat metastatic pancreatic cancer

Gaining insights into virotherapy with canine models

Lee-Hwa Tai Information

University

Position

___

Citations(all)

2177

Citations(since 2020)

1072

Cited By

1493

hIndex(all)

23

hIndex(since 2020)

17

i10Index(all)

26

i10Index(since 2020)

20

Email

University Profile Page

Google Scholar

Lee-Hwa Tai Skills & Research Interests

Cancer Immunology

Immunotherapy

Top articles of Lee-Hwa Tai

Fatty acid transport protein inhibition sensitizes breast and ovarian cancers to oncolytic virus therapy via lipid modulation of the tumor microenvironment

Frontiers in Immunology

2023/3/10

CAnAdIAn BlAdder CAnCer ForUm 2023

CUAJ

2023/3

Perioperative oncolytic virotherapy to counteract surgery-induced immunosuppression and improve outcomes in pancreatic ductal adenocarcinoma

2023/2/16

Heterologous prime-boost cellular vaccination induces potent antitumor immunity against triple negative breast cancer

Frontiers in immunology

2023/2/13

Lauren Daniel
Lauren Daniel

H-Index: 16

Lee-Hwa Tai
Lee-Hwa Tai

H-Index: 16

Gemcitabine promotes autophagy and lysosomal function through ERK-and TFEB-dependent mechanisms

Cell Death Discovery

2023/2/6

Lee-Hwa Tai
Lee-Hwa Tai

H-Index: 16

Remodeling the tumor immune microenvironment with oncolytic viruses expressing miRNAs

2023/1/4

Lauren Daniel
Lauren Daniel

H-Index: 16

Lee-Hwa Tai
Lee-Hwa Tai

H-Index: 16

Born to kill: arming oncolytic virus VSV-TNFSF14/light to treat metastatic pancreatic cancer

HPB

2023/1/1

Gaining insights into virotherapy with canine models

Molecular Therapy-Oncolytics

2023/12/19

Lee-Hwa Tai
Lee-Hwa Tai

H-Index: 16

Intratumoral administration of unconjugated Accum™ impairs the growth of pre‐established solid lymphoma tumors

Cancer Science

2023/12

Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapies

Nature communications

2023/5/26

Perioperative arginine prevents metastases by accelerating natural killer cell recovery after surgery

Molecular Therapy

2022/10/5

Leonard Angka
Leonard Angka

H-Index: 9

Lee-Hwa Tai
Lee-Hwa Tai

H-Index: 16

Intravesical immunotherapy with a GM-CSF armed oncolytic vesicular stomatitis virus improves outcome in bladder cancer

Molecular Therapy-Oncolytics

2022/3/17

Madhuri Koti
Madhuri Koti

H-Index: 21

Lee-Hwa Tai
Lee-Hwa Tai

H-Index: 16

2022 Canadian Surgery Forum Sept. 15–17, 2022: Abstracts presented at the 2022 Canadian Surgery Forum in Toronto, Ontario.

Canadian Journal of Surgery

2022/11/3

Arming beneficial viruses to treat pancreatic cancer

Canadian Journal of Surgery

2022/11/1

Yves Collin
Yves Collin

H-Index: 4

Lee-Hwa Tai
Lee-Hwa Tai

H-Index: 16

ASSESS THE CYTOTOXIC EFFECT OF NOVEL ANTI-HER2 ADCS IN AN IN VITRO MODEL OF RESISTANT BREAST CANCER

2021/5

Lee-Hwa Tai
Lee-Hwa Tai

H-Index: 16

Adjuvant melatonin for the prevention of recurrence and mortality following lung cancer resection (AMPLCaRe): a randomized placebo controlled clinical trial

EClinicalMedicine

2021/3/1

A preclinical PET dual-tracer imaging protocol for ER and HER2 phenotyping in breast cancer xenografts

EJNMMI Research

2020/12

Roger Lecomte
Roger Lecomte

H-Index: 23

Lee-Hwa Tai
Lee-Hwa Tai

H-Index: 16

848 Prime-boost vaccination for the treatment of triple negative breast cancer

2020/11/1

Lee-Hwa Tai
Lee-Hwa Tai

H-Index: 16

See List of Professors in Lee-Hwa Tai University(Université de Sherbrooke)